Australia faces a nation-wide shortage of methylphenidate (sold as Concerta and Ritalin). ADHD medication shortages have ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Stanford University researchers have discovered why some people with attention deficit hyperactivity disorder may do well on their medicine for a while but struggle down the road.

Instead, participants said, classifying methylphenidate a schedule 6 drug “ negatively impacts on treatment adherence ”. Our medicines regulator, the South African Health Products Regulatory Authority ...

Methylphenidate is a first-line treatment for ADHD and is associated with improved sleep. However, the effect of methylphenidate on sleep outcomes depends on multiple clinical and sociodemographic ...

To date, 13 trials 15 - 27 have evaluated methylphenidate versus placebo for the treatment of CRF, of which only five enrolled 100 or more participants. 15, 20, 22, 24, 27 The characteristics of the ...

Other forms of long-acting methylphenidate include the patch form (Daytrana) or Jornay, which is unique in that it is taken at night and released by the time you wake up (in theory).

You can go with a methylphenidate to dexmethylphenidate substitution (or vice versa). That is, Ritalin (mixed methylphenidates) to Focalin (dex methylphenidate) or the reverse.

More information: Xiangsheng Luo et al, Overactivated contextual visual perception and response to a single dose of methylphenidate in children with ADHD, European Archives of Psychiatry and ...

Specifically, methylphenidate is hypothesized to ameliorate ADHD symptoms by increasing dopamine levels in the nucleus accumbens (NAc), a hub for dopamine signaling.